415
Participants
Start Date
November 30, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
November 30, 2009
Loperamide/simeticone 2 mg/125 mg caplets
Oral, 2 caplets taken initially at investigator site followed by one caplet after each unformed stool, maximum 4 caplets in a 24 hour period for a maximum of 48 hours (per product label)
Loperamide/simeticone 2 mg/125 mg chewable tablets
Oral, 2 chewable tablets taken initially at the site followed by one chewable tablet after each unformed stool, maximum 4 chewable tablets in a 24 hour period for a maximum of 48 hours (per product label)
Probiotic Saccharomyces boulardii 250 mg capsules
Oral, 1 capsule twice a day, maximum 2 capsules in a 24 hour period for a maximum of 5 days (per product label)
North West Medical, San José del Cabo
Dr. Maxwell´s Clinic, San Miguel de Allende
Hospital Amerimed Puerto Vallarta, Puerto Vallarta
Servicios Medicos de la Bahia, Puerto Vallarta
Manipal Goa Hospital, Mormugao
Vrundavan Hospital & Research Centre, Mormugao
Lead Sponsor
McNeil AB
INDUSTRY